Serum Tenascin-C and Alarin Levels Are Associated with Cardiovascular Diseases in Type 2 Diabetes Mellitus

Serum Tenascin-C and Alarin Levels Are Associated with Cardiovascular Diseases in Type 2 Diabetes Mellitus

Background. Tenascin-C (TNC), an extracellular matrix glycoprotein, is elevated in inflammatory and cardiovascular pathologies, whereas alarin, a novel orexigenic peptide, participates in insulin resistance and glycometabolism. The roles of these molecules in individuals with cardiovascular disease...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mingming Li, Mengjiao Wu, Hua Zhu, Yulin Hua, Zijun Ma, Jiayi Yao, Bin Feng, Bimin Shi
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	International Journal of Endocrinology
Online Access:	http://dx.doi.org/10.1155/2022/2009724
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tenascin-C as a cardiovascular marker
by: A. M. Alieva, et al.
Published: (2022-09-01)

Tenascin-C drives cardiovascular dysfunction in a mouse model of diabetic cardiomyopathy
by: Zsuzsanna Arnold, et al.
Published: (2025-05-01)

Serum levels of galanin-like peptide and alarin are highly correlated with polycystic ovary syndrome
by: Mengchen Liu, et al.
Published: (2025-03-01)

A Correlation of Alarin with Some Anthropometric Measurements in Iraqi Type II Diabetic Patients
by: Russell S. A. Al-Shaabani, et al.
Published: (2024-12-01)

Combined loss of brevican, neurocan, tenascin-C and tenascin-R leads to impaired fear retrieval due to perineuronal net loss
by: Cornelius Mueller-Buehl, et al.
Published: (2025-02-01)

Negative regulation of lymphangiogenesis by Tenascin-C delays the resolution of inflammation
by: Daisuke Katoh, et al.
Published: (2025-02-01)

The role of tenascin-C in tumor microenvironments and its potential as a therapeutic target
by: Yaran Wang, et al.
Published: (2025-02-01)

A model for prognosis of development of left ventricular systolic dysfunction in patients with acute myocardial infarction and type 2 diabetes mellitus taking into account tenascin C level
by: M. Yu. Koteliukh
Published: (2016-03-01)

The Presence and Anti-HIV-1 Function of Tenascin C in Breast Milk and Genital Fluids.
by: Robin G Mansour, et al.
Published: (2016-01-01)

Tenascin‐C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression
by: Devadarssen Murdamoothoo, et al.
Published: (2021-05-01)

Decorin, Tenascin C, Total Antioxidant, and Total Oxidant Level Changes in Patients with Pseudoexfoliation Syndrome
by: Yavuz Oruc, et al.
Published: (2018-01-01)

The Role of Tenascin-C in Hypertrophic Scar Formation: Insights From Cell and Animal Experiments [Retraction]
by: Xiang W, et al.
Published: (2025-07-01)

Role of High Serum Tenascin C Levels as Potential Biomarker of Persistent Inflammation in Patients with Ankylosing Spondylitis Despite Treatment with cs-DMARDS or Anti-TNF Agents
by: Alejandro Martelli-Garcia, et al.
Published: (2025-06-01)

Testosterone Delays Bone Microstructural Destruction via Osteoblast‐Androgen Receptor‐Mediated Upregulation of Tenascin‐C
by: Yong Xie, et al.
Published: (2025-08-01)

SR-FTIR Biomolecular Characterization of the Hippocampus: The Role of Tenascin C in Adult Murine Neurogenesis in the Subgranular Zone
by: Milena Korenić, et al.
Published: (2025-03-01)

In Vivo and In Vitro Expression of Tenascin by HumanThymic Microenvironmental Cells
by: Claudia Sondermann Freitas, et al.
Published: (1995-01-01)

The relationship between blood urea nitrogen to serum albumin ratio and cardiovascular diseases, cardiovascular mortality, and all-cause mortality in patients with diabetes mellitus
by: Hongwei Zhu, et al.
Published: (2025-04-01)

Serum megalin levels in type-2 diabetes mellitus with and without cardiovascular disease
by: Sujatha Rajaragupathy, et al.
Published: (2024-11-01)

Tenascin-C-Matrix Metalloproteinase-3 Phenotype and the Risk of Tendinopathy in High-Performance Athletes: A Case–Control Study
by: Lucas Rafael Lopes, et al.
Published: (2024-11-01)

IL-18R supported CAR T cells targeting oncofetal tenascin C for the immunotherapy of pediatric sarcoma and brain tumors
by: Jessica Wagner, et al.
Published: (2024-11-01)

Disorders of gut microbiota and fecal–serum metabolic patterns are associated with pulmonary tuberculosis and pulmonary tuberculosis comorbid type 2 diabetes mellitus
by: Yunguang Wang, et al.
Published: (2025-08-01)

Modulation of Tumor Cell Survival, Proliferation, and Differentiation by the Peptide Derived from Tenascin-C: Implication of β1-Integrin Activation
by: Takuya Iyoda, et al.
Published: (2012-01-01)

The Correlation between Type 2 Diabetes Mellitus and Cardiovascular Disease Risk Factors in the Elderly
by: Lijuan Zhang, et al.
Published: (2022-01-01)

Tenascin-C Facilitates Microglial Polarization via TLR4/MyD88/NF-κB Pathway Following Subarachnoid Hemorrhage
by: Hu ZQ, et al.
Published: (2025-03-01)

Association of sarcopenia index, based on serum creatinine and cystatin C, with incident diabetes mellitus
by: Xuanyu Wang, et al.
Published: (2025-03-01)

Serum Cortisol, 25 (OH)D, and Cardiovascular Risk Factors in Patients with Type 2 Diabetes Mellitus
by: Yuxi Jin, et al.
Published: (2022-01-01)

Diagnostic Accuracy of Serum Cystatin C for Early Recognition of Nephropathy in Type 2 Diabetes Mellitus
by: Suman Sapkota, et al.
Published: (2021-01-01)

Association between serum carcinoembryonic antigen levels and atherosclerotic cardiovascular disease in patients with type 2 diabetes mellitus
by: You-Fan Peng, et al.
Published: (2025-07-01)

DIABETES MELLITUS AND CARDIOVASCULAR COMPLICATIONS: FOCUS ON HEMOSTASIS
by: G. G. Petrik, et al.
Published: (2014-03-01)

Correlation Between Serum Uric Acid, Insulin and Hba1c In Type 2 Diabetes Mellitus
by: Maryam Imtiaz, et al.
Published: (2024-06-01)

Serum osteocalcin levels in type I diabetes mellitus
by: H Paşaoğlu, et al.
Published: (1995-10-01)

Integrative analyses of 16S rDNA sequencing and serum metabolomics demonstrate significant roles for the oral microbiota and serum metabolites in post-kidney transplant diabetes mellitus
by: Chao Liu, et al.
Published: (2025-07-01)

Sulfonylureas and cardiovascular complications of type 2 diabetes mellitus
by: Lyudmila Viktorovna Nedosugova
Published: (2013-06-01)

Therapy potential for the correction of cardiovascular disturbances in diabetes mellitus
by: I. P. Tatarchenko, et al.
Published: (2012-08-01)

PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN DIABETES MELLITUS: THE ROLE OF ASPIRIN
by: L. A. Strizhakov
Published: (2012-04-01)

Vitamin B6, cardiovascular diseases, and diabetes mellitus
by: A.A. Serhiyenko, et al.
Published: (2025-03-01)

Gestational Diabetes Mellitus and Future Cardiovascular Risk: An Update
by: S. Burlina, et al.
Published: (2016-01-01)

Association between Serum Uric Acid Levels and Diabetes Mellitus
by: Pavani Bandaru, et al.
Published: (2011-01-01)

Serum markers of bone fragility in type-2 diabetes mellitus
by: Rucsandra Dănciulescu Miulescu, et al.
Published: (2019-05-01)

Serum 25-hydroxyvitamin D levels in relation to lipids and clinical outcomes in pregnant women with gestational diabetes mellitus: an observational cohort study
by: Yuan Li, et al.
Published: (2020-11-01)